Manufacturing Cures: Infrastructure Challenges Facing Cell And Gene Therapy Developers
To Ensure Broad Patient Access To Cell And Gene Therapies Stakeholders Must Address Manufacturing Challenges
Executive Summary
As more regenerative medicine products approach clinical testing and commercialization, stakeholders in the field are increasingly pressed to address substantial challenges, including pricing and reimbursement, GMP manufacturing, and clinical availability, and patient accessibility to these life changing therapies.